摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-Nitrophenyl)-3-butyn-1-ol | 83816-47-1

中文名称
——
中文别名
——
英文名称
1-(4-Nitrophenyl)-3-butyn-1-ol
英文别名
1-(4-nitrophenyl)but-3-yn-1-ol
1-(4-Nitrophenyl)-3-butyn-1-ol化学式
CAS
83816-47-1;132927-19-6
化学式
C10H9NO3
mdl
——
分子量
191.186
InChiKey
RPIMUJOTKHMQIL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-Nitrophenyl)-3-butyn-1-ol溶剂黄1462-乙氧基-1-乙氧碳酰基-1,2-二氢喹啉 作用下, 以 甲醇二氯甲烷 为溶剂, 生成 (9H-fluoren-9-yl)methyl N-[(1S)-1-{[(1S)-4-(carbamoylamino)-1-{[4-(1-hydroxybut-3-yn-1-yl)phenyl]carbamoyl}butyl]carbamoyl}-2-methylpropyl]carbamate
    参考文献:
    名称:
    LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME
    摘要:
    lt provides linker compounds, or stereoisomers or salts thereof, including (a) a linker unit having from 1 to 4 attachment sites for a drug unit and having one of the following structures (i) or (ii): (b) at least one polar group containing a polymer unit, optionally a sugar unit, optionally a carboxyl unit, and combinations thereof; and (c) optionally a stretcher group having an attachment site for a targeting group, wherein a-is an attachment site to an enzyme- cleavable group; (3-is an attachment site to the at least one polar group; 6-is H, an attachment site to at least one of the drug unit, or an attachment site to a linking group attached to the at least one of the drug unit. It also provides drug-linker compounds and conjugates formed from linker compounds, as well as related pharmaceutical compositions and methods.
    公开号:
    WO2024149345A1
  • 作为产物:
    参考文献:
    名称:
    SHAO, QIU-YI;GAO, XIANG;SHUN, PEI-DONG, YUTSZI XUASYUEH, 11,(1991) N, S. 195-198
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Allenone-Mediated Racemization/Epimerization-Free Peptide Bond Formation and Its Application in Peptide Synthesis
    作者:Zhengning Wang、Xuewei Wang、Penghui Wang、Junfeng Zhao
    DOI:10.1021/jacs.1c04614
    日期:2021.7.14
    peptide synthesis (SPPS). The robustness of the allenone-mediated peptide bond formation was showcased incisively by the synthesis of carfilzomib, which involved a rare racemization-/epimerization-free N to C peptide elongation strategy. Furthermore, the successful synthesis of the model difficult peptide ACP (65–74) on a solid support suggested that this method was compatible with SPPS. This method combines
    Allenone 首次被鉴定为一种高效的肽偶联剂。肽键以α-羰基乙烯基酯为关键中间体形成,其形成和随后的解以无外消旋/差向异构化的方式自发进行。丙二烯酮偶联试剂不仅对简单酰胺和二肽的合成有效,而且还适用于肽片段缩合和固相肽合成 (SPPS)。卡非佐米的合成充分展示了丙二烯酮介导的肽键形成的稳健性,该合成涉及一种罕见的无消旋化/差向异构化的 N 到 C 肽延伸策略。此外,在固体支持物上成功合成模型困难肽 ACP (65-74) 表明该方法与 SPPS 兼容。该方法结合了传统活性酯和偶联剂的优点,同时克服了两种策略的缺点。因此,这种丙二烯酮介导的肽键形成策略代表了肽合成的颠覆性创新。
  • Regioselective Addition Reactions of Propargyl Bromides to Carbonyl Compounds with Gallium Catalyzed by Indium
    作者:Phil Ho Lee、Hyun Kim、Kooyeon Lee
    DOI:10.1002/adsc.200505046
    日期:2005.7
    propargyl bromides having substituents at the γ-position and gallium in the presence of 5 mol % of indium with aldehydes and ketones selectively produced homoallenyl alcohols in good to excellent yields. Treatment of organogallium reagents obtained from propargyl bromide or propargyl bromides having substituents at the α-position and gallium in the presence of 5 mol % of indium with carbonyl compounds selectively
    在5mol%的存在下,由在γ-位具有取代基的炔丙基产生的有机试剂与醛和酮的反应选择性地以良好或优异的产率产生了高均烯基醇。在5mol%的存在下,用羰基化合物处理由在α位具有取代基的炔丙基或炔丙基获得的有机试剂,选择性地得到高炔丙醇
  • Efficient method for propargylation of aldehydes promoted by allenylboron compounds under microwave irradiation
    作者:Jucleiton J R Freitas、Queila P S B Freitas、Silvia R C P Andrade、Juliano C R Freitas、Roberta A Oliveira、Paulo H Menezes
    DOI:10.3762/bjoc.16.19
    日期:——
    The propargylation of aldehydes promoted by microwave irradiation using allenylboron compounds in a chemo- and regioselective way is described. The corresponding products were obtained in short reaction time, high yield and purity without the need of any solvent when allenylboronic acid pinacol ester was used, or using a minimal amount of acetone when potassium allenyltrifluoroborate was used.
    描述了通过使用烯丙基化合物通过微波辐射以化学和区域选择性方式促进的醛的炔丙基化。当使用烯丙基硼酸频哪醇酯时,不需要任何溶剂,反应时间短,产率高,纯度高,而使用烯丙基三硼酸时,所使用的丙酮量少。
  • A facile lipase-catalyzed KR approach toward enantiomerically enriched homopropargyl alcohols
    作者:Paweł Borowiecki、Maciej Dranka
    DOI:10.1016/j.bioorg.2019.01.050
    日期:2019.12
    (E ≫ 500) furnishing both resolution products of the racemic 1-phenylbut-3-yn-1-ol in highly enantiomerically enriched form (up > 99% ee). Variable reaction parameters, such as the acyl-group donor reagent as well as solvent, were additionally screened to establish their impact on the stereochemical outcome. For optimal biocatalytic systems established with model substrate, the enzymatic transformations were
    具有炔丙基(丙-2-炔)体系的化合物是有机化学非常重要的组成部分。其中,对映体高炔丙醇(but-3-yn-1-ols)的制备构成了不对称合成的关键挑战,因此在过去的几十年中引起了合成界的极大关注。在这项工作中,已经研究了一组商业脂肪酶的催化性能,用于在动力学控制的条件下对1-苯基高炔丙基醇进行对映选择性酯交换。固定在陶瓷(Amano PS-C II)或藻土(Amano PS-IM)上的洋葱伯克霍尔德氏菌(BCL)的脂肪酶是最活跃和对映选择性的酶制剂(E ≫ 500)提供了高度对映体富集形式的外消旋1-苯基丁-3-炔-1-醇的两种拆分产物(大于99%ee)。另外还筛选了可变的反应参数,例如酰基供体试剂和溶剂,以确定它们对立体化学结果的影响。对于建立有模型底物的最佳生物催化系统,酶促转化扩展到了其他8种不同的对苯基取代的均丙基仲醇的制备规模KR ,从而合成了(S)醇(96-100%ee )和
  • A bicyclization reaction with two molecular allenyl ketones and isocyanides: synthesis of a lactone-containing azaspirocycle derivative
    作者:Hongdong Yuan、Chongrong Tang、Shikuan Su、Lei Cui、Xueshun Jia、Chunju Li、Jian Li
    DOI:10.1039/c9cc02785h
    日期:——
    A novel bicyclization reaction of two molecular allenyl ketones and isocyanides has been disclosed. This strategy allows for the construction of structurally complex spirocyclic lactam–lactone systems in an efficient manner. This protocol also demonstrates other advantages such as high synthetic efficiency, atom economy, and broad substrate scope under mild conditions.
    已经公开了两种分子烯基酮和异氰酸酯的新型双环化反应。这种策略可以有效地构建结构复杂的螺内酰胺-内酯体系。该协议还证明了其他优点,例如合成效率高,原子经济性好,在温和条件下的底物范围广。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫